ARTICANZ - Beta (ver 0.91)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - location/SA/5000-South-Australia-GenesisCare-St-Andrews-Hospital
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
10
trial(s) found.
NCT07173751
Advanced
Phase 3
Recruiting
A Phase III, Multisite, Randomized, Double-Blind Trial of BNT327 in Combination With Chemotherapy Versus Placebo With Chemotherapy in Patients With Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC Determined Ineligible for PD(L)1 Therapy Based on PD-L1 Negative Disease (
BNT327-05
)
bispecific PD-L1/VEGFA antibody
placebo
Breast cancer
VIC
3199 - Frankston - Peninsula Health Frankston Hospital
SA
5000 - South Australia - GenesisCare St Andrews Hospital
NCT06923761
Advanced
Phase 1 / Phase 2
Recruiting
A Modular, Multi-part, Multi-arm, Open-label, Phase I/II Study to Evaluate the Safety and Tolerability of GRWD5769 Alone and in Combination With Anticancer Treatments in Patients With Solid Malignancies (
EMITT-1
)
ERAP1 inhibitor
Solid tumour
NSW
2010 - Darlinghurst - St Vincent's Hospital Sydney - The Kinghorn Cancer Centre
2148 - Blacktown - Blacktown Hospital, Blacktown Cancer and Haematology Centre
2500 - Wollongong - Cancer Care Wollongong
VIC
3004 - Melbourne, Southbank - Alfred Health
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
QLD
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre
SA
5000 - South Australia - GenesisCare St Andrews Hospital
5042 - Bedford Park - Southern Oncology Clinical Research Unit
NCT06855771
Advanced
Phase 2
Recruiting
A Multicenter, Randomized, Open-label, Phase 2 Study Evaluating the Safety and Efficacy of BMS-986504 Monotherapy in Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion After Progression on Prior Therapies (
CA240-0009
)
PRMT5 inhibitor,MTA-co-operative
Non-small cell lung cancer
NSW
2050 - Camperdown - Chris O'Brien Lifehouse
2560 - Campbelltown - GenesisCare Campbelltown
QLD
4102 - Woolloongabba - Princess Alexandra Hospital
SA
5000 - South Australia - GenesisCare St Andrews Hospital
NCT06819007
Advanced
Phase 3
Recruiting
A Phase 3, Open-label, Multicenter, Randomized Trial of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy as First-line Maintenance Therapy in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01/ENGOT-ov89/GEICO144- O/GOG-3112/APGOT-OV13) (
DO-01
)
anti-ERBB2 antibody-drug conjugate
anti-VEGF monoclonal antibody
Ovarian cancer
NSW
2065 - St Leonards - GenesisCare North Shore Private Hospital
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
QLD
4066 - Auchenflower - Icon Cancer Centre at Wesley Hospital
SA
5000 - South Australia - GenesisCare St Andrews Hospital
TAS
7000 - Hobart - ICON Cancer Care Hobart
NCT06770569
Advanced
Phase 1
Recruiting
Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors: a Single-arm, Open, Multicenter Phase I Study (
HRS-3802-101
)
unknown drug class
Solid tumour
NSW
2065 - St Leonards - GenesisCare North Shore Private Hospital
2109 - North Ryde - Macquarie University Hospital
VIC
3199 - Frankston - Peninsula Health Frankston Hospital
QLD
4224 - Tugun - Genesis Care Tugun - John Flynn Private Hospital
SA
5000 - South Australia - GenesisCare St Andrews Hospital
NCT06757634
Advanced
Phase 3
Recruiting
VIKTORIA-2: A Randomized, Open-Label, Phase 3 Study of Fulvestrant and CDK4/6 Inhibitors With or Without Gedatolisib as First-Line Treatment in Patients With HR-Positive and HER2-Negative Advanced Breast Cancer (
CELC-G-302
)
pan-PI3K/mTORC1/mTORC2 inhibitor
selective estrogen receptor degrader
Breast cancer
NSW
2076 - Wahroonga - Sydney Adventist Hospital
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
QLD
4215 - Southport - ICON Cancer Care
SA
5000 - South Australia - GenesisCare St Andrews Hospital
5011 - Woodville South - The Queen Elizabeth Hospital
WA
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre
NCT06161025
Advanced
Phase 2 / Phase 3
Recruiting
A Phase 2/3, Multicenter, Randomized Study of Raludotatug Deruxtecan (R-DXd), a CDH6-directed Antibody-drug Conjugate, in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (
DS6000-109
)
anti-CDH6 antibody-drug conjugate
Solid tumour
NSW
2065 - St Leonards - GenesisCare North Shore Private Hospital
SA
5000 - South Australia - GenesisCare St Andrews Hospital
NCT06120283
Advanced
Phase 1
Recruiting
A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of the CDK4 Inhibitor BGB-43395, Alone or as Part of Combination Therapies in Patients With Metastatic HR+/HER2- Breast Cancer and Other Advanced Solid Tumors (
BGB-43395-101
)
CDK4 selective inhibitor
Breast cancer
Cancer
HER2-negative breast cancer
HR-positive breast cancer
Non-small cell lung cancer
Solid tumour
NSW
2109 - North Ryde - Macquarie University Hospital
2139 - Concord - Concord Repatriation General Hospital
2148 - Blacktown - Blacktown Hospital, Blacktown Cancer and Haematology Centre
2576 - Bowral - Southern Highlands Private Hospital
VIC
3000 - Melbourne - Peter MacCallum Cancer Centre
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
QLD
4814 - Douglas - Townsville Cancer Centre - The Townsville Hospital
SA
5000 - South Australia - GenesisCare St Andrews Hospital
NZ
NZ.1023 - Grafton - Auckland City Hospital - Cancer & Blood Research
NZ.8011 - Christchurch - Canterbury District Health Board - Christchurch Hospital Cancer Centre
NCT05950945
Advanced
Phase 3
Recruiting
A Phase 3b, Multicenter, Global, Interventional, Open-label Study of Trastuzumab Deruxtecan (T-DXd), an Anti-HER2-Antibody Drug Conjugate (ADC), in Subjects Who Have Unresectable and/or Metastatic HER2-low or HER2 Immunohistochemistry (IHC) 0 Breast Cancer (DESTINY-Breast15) (
DS8201-0001-CIS-MA
)
anti-ERBB2 antibody-drug conjugate
Breast cancer
NSW
2060 - North Sydney - Mater Hospital
VIC
3165 - East Bentleigh - Peter MacCallum Cancer Centre Moorabbin Campus
SA
5000 - South Australia - GenesisCare St Andrews Hospital
WA
6150 - Murdoch - Fiona Stanley Hospital
NCT05417516
Radonc
Phase 3
Recruiting
A Randomized Trial of Five-Fraction Partial Breast Irradiation (RAPID2) (
OCOG-2022-RAPID2
)
Breast cancer
NSW
2060 - Sydney - GenesisCare Mater
2220 - Hurstville - GenesisCare Hurstville
QLD
4215 - Southport - GenesisCare
4224 - Tugun - Genesis Care Tugun - John Flynn Private Hospital
4655 - Urraween - GenesisCare Hervey Bay
4670 - Bundaberg - Bundaberg Hospital, Genesis Cancer Care
SA
5000 - South Australia - GenesisCare St Andrews Hospital
WA
6009 - Nedlands - Hollywood Private Hospital
6014 - Wembley - GenesisCare Wembley
6150 - Murdoch - GenesisCare Murdoch
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Recruiting (10)
Recruitment Country and State
SA (10)
NSW (9)
QLD (7)
VIC (5)
WA (3)
TAS (1)
NZ (1)
Phase
Phase 1 (2)
Phase 1 / Phase 2 (1)
Phase 2 (1)
Phase 2 / Phase 3 (1)
Phase 3 (5)
Trial Type
Advanced (9)
Radonc (1)
Cancer Therapy Class
PD-1/PD-L1
20%
ERBB2
20%
CDK4
20%
ER
20%
oestrogen axis
20%
PD-L1
10%
VEGFA
10%
ERAP1
10%
PD-1
10%
PRMT5
10%
VEGF
10%
CDK6
10%
PI3K
10%
PI3Kalpha
10%
mTOR
10%
mTORC1
10%
mTORC2
10%
CDH6
10%
CDK4 selective
10%
Facility
5000 - South Australia - GenesisCare St Andrews Hospital (10)
2065 - St Leonards - GenesisCare North Shore Private Hospital (3)
3199 - Frankston - Peninsula Health Frankston Hospital (2)
2148 - Blacktown - Blacktown Hospital, Blacktown Cancer and Haematology Centre (2)
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre (2)
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital (2)
2109 - North Ryde - Macquarie University Hospital (2)
4224 - Tugun - Genesis Care Tugun - John Flynn Private Hospital (2)
2010 - Darlinghurst - St Vincent's Hospital Sydney - The Kinghorn Cancer Centre (1)
2500 - Wollongong - Cancer Care Wollongong (1)
3004 - Melbourne, Southbank - Alfred Health (1)
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre (1)
5042 - Bedford Park - Southern Oncology Clinical Research Unit (1)
2050 - Camperdown - Chris O'Brien Lifehouse (1)
2560 - Campbelltown - GenesisCare Campbelltown (1)
4102 - Woolloongabba - Princess Alexandra Hospital (1)
4066 - Auchenflower - Icon Cancer Centre at Wesley Hospital (1)
7000 - Hobart - ICON Cancer Care Hobart (1)
2076 - Wahroonga - Sydney Adventist Hospital (1)
4215 - Southport - ICON Cancer Care (1)
5011 - Woodville South - The Queen Elizabeth Hospital (1)
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre (1)
2139 - Concord - Concord Repatriation General Hospital (1)
2576 - Bowral - Southern Highlands Private Hospital (1)
3000 - Melbourne - Peter MacCallum Cancer Centre (1)
4814 - Douglas - Townsville Cancer Centre - The Townsville Hospital (1)
NZ.1023 - Grafton - Auckland City Hospital - Cancer & Blood Research (1)
NZ.8011 - Christchurch - Canterbury District Health Board - Christchurch Hospital Cancer Centre (1)
2060 - North Sydney - Mater Hospital (1)
3165 - East Bentleigh - Peter MacCallum Cancer Centre Moorabbin Campus (1)
6150 - Murdoch - Fiona Stanley Hospital (1)
2060 - Sydney - GenesisCare Mater (1)
2220 - Hurstville - GenesisCare Hurstville (1)
4215 - Southport - GenesisCare (1)
4655 - Urraween - GenesisCare Hervey Bay (1)
4670 - Bundaberg - Bundaberg Hospital, Genesis Cancer Care (1)
6009 - Nedlands - Hollywood Private Hospital (1)
6014 - Wembley - GenesisCare Wembley (1)
6150 - Murdoch - GenesisCare Murdoch (1)
Cancer Type
Cancer
Solid tumour
Breast cancer
Lung cancer
Non-small cell lung cancer
Respiratory tract cancer
Thoracic cancer
Gynaecological cancer
Ovarian cancer
Breast adenocarcinoma
HER2-negative breast cancer
HR-positive breast cancer
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy